Revolutionizing Diabetes Treatment: Alpha Cells as Natural GLP-1 Producers

New research reveals pancreatic alpha cells can naturally produce GLP-1, a hormone that boosts insulin and may transform type 2 diabetes treatment by leveraging the body's own hormone production mechanisms.
Recent research from Duke University School of Medicine has challenged traditional views on blood sugar regulation by revealing an unexpected function of pancreatic alpha cells. Previously thought to only produce glucagon—a hormone involved in raising blood sugar during fasting or exercise—these cells are now found to also generate GLP-1, a potent hormone that enhances insulin release and helps regulate glucose levels. Using advanced mass spectrometry techniques, scientists discovered that human alpha cells naturally produce higher levels of bioactive GLP-1 than previously recognized, and this production is directly linked to insulin secretion.
Led by Dr. Jonathan Campbell, the research team examined pancreatic tissues from humans and mice across various ages, weights, and diabetic conditions. Their findings suggest that alpha cells are more adaptable, capable of adjusting hormone output to support beta cells and maintain blood sugar homeostasis. Notably, when glucagon production was blocked in mouse models, alpha cells increased GLP-1 produção, which improved glucose control and stimulated greater insulin release—indicating that GLP-1 can compensate when glucagon synthesis is inhibited.
This discovery has significant implications for diabetes treatment. Although GLP-1 is mainly produced in the gut, this study confirms pancreatic alpha cells can also secrete this hormone into the bloodstream after eating, contributing to blood sugar regulation. Mild metabolic challenges, such as high-fat diets, can modestly boost GLP-1 production from alpha cells, opening new avenues for therapies that aim to enhance the body's natural hormone production. The research team developed a precise mass spectrometry assay to measure bioactive GLP-1 accurately, which may facilitate future studies on boosting GLP-1 levels.
Dr. Campbell emphasizes that these findings suggest the body has a built-in contingency plan: in times of metabolic stress, alpha cells switch from producing glucagon to generating GLP-1, providing a natural mechanism to support insulin secretion and maintain glucose balance. This hormone shift could pave the way for innovative diabetes treatments that harness the body's own cells to produce GLP-1, potentially offering more natural and effective management of blood sugar levels.
Source: https://medicalxpress.com/news/2025-09-alpha-cells-moonlight-secret-glp.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Comprehensive Sequencing Study Finds Limited Connection Between Microbiome and Cancer
A large-scale sequencing study reveals that the presence of microbiomes in cancer tissues is much lower than previously thought, questioning their role in tumor development and diagnostics.
US Health Authorities Review Safety of COVID Vaccines in Pregnant Women and Children
U.S. health officials are reviewing safety data on COVID-19 vaccines for pregnant women and children, amid ongoing discussions and studies on vaccine safety and potential risks. The evaluation aims to ensure public health safety and may influence future vaccination guidelines.
Clinical-Community Initiative Tackles Menstrual Poverty Among Youth
A pioneering program at Wake Forest Health integrates screening and free menstrual products into pediatric care, aiming to eliminate menstrual poverty among youth and improve health outcomes.
Innovative Approaches to Gentle Dental Care for Anxious Patients
Discover innovative, minimally invasive dental treatments like silver diamine fluoride, ART, and the Hall technique that make dental visits less stressful and more comfortable for anxious patients.